[Form 4] Cerence Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cerence Inc. (CRNC) reported an insider equity award for its CFO. On 11/21/2025, the chief financial officer acquired 166,821 shares of Cerence common stock at $10.35 per share, increasing beneficial ownership to 443,552 shares held directly. The filing explains that this grant represents achieved performance stock units under the FY25 plan, which are scheduled to vest in November 2027. This ties the executive’s compensation more closely to the company’s longer-term performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rodriquez Antonio

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	166,821	$10.35	$1.73M

Holdings After Transaction: Common Stock — 443,552 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rodriquez Antonio

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		A		166,821(1)	A	$10.35	443,552	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This represents achieved PSUs under the FY25 plan that will vest in November 2027.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cerence (CRNC) report in this Form 4?

The Form 4 reports that the Cerence Inc. chief financial officer acquired 166,821 shares of common stock on 11/21/2025.

At what price were the Cerence (CRNC) shares acquired by the CFO?

The CFO’s reported acquisition was at a price of $10.35 per share for Cerence common stock.

How many Cerence (CRNC) shares does the CFO own after this transaction?

Following the reported transaction, the CFO beneficially owns 443,552 shares of Cerence common stock directly.

What type of equity award is disclosed for the Cerence (CRNC) CFO?

The filing states that the grant represents achieved performance stock units (PSUs) under the FY25 plan.

When will the reported Cerence (CRNC) PSUs vest for the CFO?

The explanation notes that these achieved PSUs are scheduled to vest in November 2027.

What is the reporting person’s role at Cerence (CRNC)?

The reporting person in this Form 4 is identified as an officer of Cerence Inc., serving as the CFO.